Clinical Trial Update: Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients [Phase 4]

View source ↗

Summary

Phase 4 study results evaluating the EULAR-RAID score in patients with rheumatoid arthritis; sponsor Wyeth (now part of Pfizer). The study has been completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2011-04-21